Miniature model of the human nose reveals early events of SARS-CoV-2 and RSV infection
Researchers anticipate that the human nose organoid system would help accelerate the transfer of lab-developed therapeutics to the bedside.
Read more
SARS-CoV-2
Innovative, faster and more cost-effective technology identifies drug that inhibits SARS-CoV-2 growth in the lab
Baylor College of Medicine researchers are contributing to the development of antiviral drugs to treat people with COVID-19.
Read more
Image of the Month: Human airway organoids infected with SARS-CoV-2
Immunofluorescence staining of human nose organoid cultures infected with SARS-CoV-2, the virus that causes COVID-19.
Read more
New COVID-19 vaccine formulation produces effective vaccine candidate
Novel vaccine candidate will be easy to produce at large scale and cost-effective, especially in low- to middle-income countries.
Read more